Svelte Medical Systems has completed 6 month follow up in its initial clinical trial with the Svelte Acrobat angioplasty system.
The Svelte Acrobat is a low profile ‘All in One’ stenting system with balloon control technology designed to reduce time and cost and improve safety in an angioplasty procedure.
Institute Dante Pazzanese de Cardiologia, Sao Paulo Coronary Interventions chief Alexandre Abizaid said the system has the ability to reduce time and costs in a procedure by allowing more lesions to be treated without pre-dilatation.
"The small size and flexibility of the system are well suited for the radial access approach," Abizaid said.
The company has a drug eluting version under development using a novel non-inflammatory bio-erodible carrier for the drug.